The Hematologist offers podcasts that enhance the reading experience by presenting key results and additional insights from published articles in a convenient audio format. All of the podcasts are available for FREE!
Where to Listen
Listen to the podcasts below (Internet connection required) or download and listen to them later via Spotify, Apple Podcasts, or wherever you find your podcasts.
Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients
September 12, 2025
Speakers: Samuel Wilson, MD, Francis Couturaud, MD, PhD
In this episode, Contributing Editor Samuel Wilson, MD, talks with Francis Couturaud, MD, PhD, Professor of Pulmonology at University of Brest in France. They discuss low-dose direct oral anticoagulants for extended venous thromboembolism prophylaxis.
GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias
August 17, 2025
Speakers: Lauren Pommert, MD, MS, Karen Rabin, MD, PhD, Hans Hitzler, MD
In this episode, Contributing Editor, Lauren Pommert, MD, MS, leads a conversation with Karen Rabin, MD, PhD, pediatric oncologist at the University of California, San Francisco, and Hans Hitzler, MD, with SickKids Children's Hospital in Toronto. They discuss advances in understanding the disease biology of down syndrome associated acute leukemia. Support for this episode provided by Autolus.
More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia
July 28, 2025
Speakers: Lori Muffly, MD, MS, Matt, and Rohan
In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients —Matt and Rohan — both of whom have undergone cord blood transplants for their acute myeloid leukemia. They discuss the value of peer connection as a vital component of their leukemia and transplant journey.
Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia
June 23, 2025
Speakers: Surbhi Shah, MBBS, MD, and Keith McCrae, MD
In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of classical hematology at the Taussig Cancer Institute and professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine in Ohio. They discuss a recent paper co-authored by Dr. McCrae, “Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.” Support for this episode provided byAutolus.
The Hematologist: ASH News and Reports
Advertisement intended for health care professionals
